Labiotech.eu

gene therapy cell therapy advanced therapy 4BIO

News and Trends 9 Sep 2019

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

The London-based life sciences investor 4BIO Capital has raised €45M in the first close of a fund to nurture companies developing advanced therapies such as gene and cell therapies. This is the first closing of 4BIO’s second fund, called 4BIO Ventures II, which is expected to total €136M ($150M) by late 2020. The fund will […]

September 9, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 9 Sep 2019

Top 10 Food Tech Companies in Europe in 2019

Food tech companies in Europe are striving to change how food is made to bring us closer to a more sustainable future. Here are some of the top companies you’ll find in this field. Food doesn’t just keep us alive, it is part of our culture and our daily routine, and it plays a key […]

September 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Expert Advice 7 Sep 2019

Why Being in a New Field From the Start Can Pay Off in the Long Run

The field of immuno-oncology has expanded out of all recognition over the last few years. Having co-founded one of the first cancer immunotherapy biotechs — Immatics — CEO Harpreet Singh has seen it all happen. He plans to take advantage of the company’s head start to tackle solid tumors with its T-cell redirecting therapies. Singh […]

September 7, 2019 - 12 minutesmins - By Helen Albert

Startup Scout 6 Sep 2019

This Biotech Regenerates Bone Tissue to Treat Tooth Loss

In the university town of Umeå, Sweden, the biotech company Omnio is developing treatments for tooth loss in conditions such as periodontitis. Mission: To promote wound healing by enhancing the action of plasminogen, a protein in the blood that is important in the healing process. Enhancing the action of this molecule could allow the company […]

September 6, 2019 - 4 minutesmins - By Jonathan Smith

cardiology astrazeneca novartis cardiovascular disease

News and Trends 5 Sep 2019

Top Cardiology Biotech News from the ESC Conference 2019

Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest research into cardiovascular diseases. Read on for a roundup of the most exciting cardiology news from the biotech scene. The European Society of Cardiology teamed up with the World Heart Federation this year to arrange a conference themed on global […]

September 5, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 5 Sep 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

Orchard Therapeutics’ gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than six times over the target endpoint, according to data released at a recent symposium. “Metachromatic leukodystrophy is a rare disease that affects the brain,” explained Mark Rothera, CEO of Orchard Therapeutics. “Kids born with MLD lose motor function very fast […]

September 5, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Sep 2019

US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance

The German biotech Curetis has been combined with the US genomics company OpGen to pool their molecular diagnostics expertise in the fight against antibiotic resistance. “After more than one year of intensive discussions and negotiations for many months, it feels great to be able to announce the transaction today,” Oliver Schacht, the CEO of Curetis, […]

September 4, 2019 - 3 minutesmins - By Jonathan Smith

Interview 4 Sep 2019

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas Lingelbach, shared his experience of migrating from big pharma to biotech, and how his first biotech company weathered phase III failures to develop vaccines for neglected diseases. Once confined to the less developed regions of the world, many insect-borne diseases […]

September 4, 2019 - 9 minutesmins - By Jonathan Smith

News and Trends 3 Sep 2019

Gyroscope Targets Age-Related Blindness with €55M Series B

UK gene therapy biotech Gyroscope Therapeutics has secured €55.4M in Series B funding to target age-related macular degeneration. Life sciences investor Syncona, which is backed by the UK’s Wellcome Trust, continued its support of the company contributing €52.7M to the round. This brings its total investment in Gyroscope to €90M since the biotech was founded […]

September 3, 2019 - 2 minutesmins - By Helen Albert

cancer cell therapy immunotherapy achilles therapeutics

News and Trends 3 Sep 2019

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell immunotherapies in humans for the first time. The large Series B round will fund two phase I/IIa clinical trials of Achilles’ preclinical immunotherapy which are expected to start this year: one in non-small cell lung cancer and the other in […]

September 3, 2019 - 2 minutesmins - By Jonathan Smith

DIY diabetes community artificial pancreas

In Depth 2 Sep 2019

How the DIY Diabetes Community Made the Artificial Pancreas Possible

Six years ago, his three-year-old daughter was diagnosed with type 1 diabetes. This led Milos Kozak, a software developer from Prague, to join the DIY diabetes community. “After the diagnosis, I started to look for some solutions because I was really disappointed by the technology available on the market for diabetes,” Kozak told me. That’s […]

September 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

Startup Scout 30 Aug 2019

This Biotech Develops Epigenetic Drugs to Fight Brain Cancer

Nestled in the historic city of Uppsala, Sweden, Beactica is fighting the brain cancer glioblastoma by targeting mechanisms controlling the expression of cancer cell genes. Mission: Develop first-in-class drugs for brain cancer that block a protein called lysine-specific demethylase 1 that helps cancer cells to divide and grow. Beactica targets glioblastoma, a highly aggressive brain […]

August 30, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

Top 10 Food Tech Companies in Europe in 2019

Why Being in a New Field From the Start Can Pay Off in the Long Run

This Biotech Regenerates Bone Tissue to Treat Tooth Loss

Top Cardiology Biotech News from the ESC Conference 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

Gyroscope Targets Age-Related Blindness with €55M Series B

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

How the DIY Diabetes Community Made the Artificial Pancreas Possible

This Biotech Develops Epigenetic Drugs to Fight Brain Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!